header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FISH-150901-22413
Fish name: AB + MO5-sdc2
Genotype: AB
Targeting Reagent: MO5-sdc2
HUMAN DISEASE MODELED by AB + MO5-sdc2
No data available
GENE EXPRESSION
Gene expression in AB + MO5-sdc2
Reporter gene expression No data available
PHENOTYPE
Phenotype in AB + MO5-sdc2
Phenotype Conditions Figures
apoptotic process occurrence, normal standard conditions Fig. S2 with image from Arrington et al., 2013
basement membrane organization disrupted, abnormal standard conditions Fig. 3 with image from Arrington et al., 2009
cell migration involved in heart development disrupted, abnormal standard conditions Fig. 2 with image from Arrington et al., 2009
determination of left/right asymmetry in lateral mesoderm process quality, abnormal standard conditions Fig. 1 with image from Arrington et al., 2013
digestive tract development disrupted, abnormal standard conditions Fig. 2 with image from Arrington et al., 2009
epithelial cilium movement involved in determination of left/right asymmetry process quality, abnormal standard conditions Fig. 3 with image from Arrington et al., 2013
extension morphology, abnormal standard conditions Fig. 2 with image from Arrington et al., 2009
forerunner cell group physical object quality, abnormal standard conditions Fig. 5 with image from Arrington et al., 2013
heart symmetry, abnormal standard conditions Fig. 1 with image from Arrington et al., 2013
heart development disrupted, abnormal standard conditions Fig. 2 with image from Arrington et al., 2009
heart looping process quality, abnormal standard conditions Fig. 1 with image from Arrington et al., 2013
Kupffer's vesicle decreased size, abnormal standard conditions Fig. 2 with imageFig. 6 with image from Arrington et al., 2013
Kupffer's vesicle malformed, abnormal standard conditions Fig. 2 with imageFig. 6 with image from Arrington et al., 2013
Kupffer's vesicle morphology, normal chemical treatment: messenger RNA Fig. 6 with image from Arrington et al., 2013
Kupffer's vesicle physical object quality, abnormal standard conditions Fig. 4 with image from Arrington et al., 2013
Kupffer's vesicle size, normal chemical treatment: messenger RNA Fig. 6 with image from Arrington et al., 2013
Kupffer's vesicle motile cilium decreased amount, abnormal standard conditions Fig. 3 with imageFig. 6 with image from Arrington et al., 2013
Kupffer's vesicle motile cilium decreased length, abnormal chemical treatment: messenger RNA Fig. 6 with image from Arrington et al., 2013
Kupffer's vesicle motile cilium decreased length, abnormal standard conditions Fig. 3 with imageFig. 6 with image from Arrington et al., 2013
Kupffer's vesicle motile cilium normal amount, normal chemical treatment: messenger RNA Fig. 6 with image from Arrington et al., 2013
Kupffer's vesicle development process quality, abnormal standard conditions Fig. 2 with imageFig. 4 with imageFig. 6 with image from Arrington et al., 2013
lateral plate mesoderm symmetry, abnormal standard conditions Fig. 1 with image from Arrington et al., 2013
pericardium edematous, abnormal standard conditions Fig. 2 with image from Arrington et al., 2009
pigmentation decreased occurrence, abnormal standard conditions Fig. 2 with image from Arrington et al., 2009
regulation of fibroblast growth factor receptor signaling pathway process quality, abnormal standard conditions Fig. 4 with image from Arrington et al., 2013
supramolecular fiber organization disrupted, abnormal standard conditions Fig. 4 with image from Arrington et al., 2009
whole organism decreased size, abnormal standard conditions Fig. 2 with image from Arrington et al., 2009
whole organism morphology, normal standard conditions Fig. 2 with image from Arrington et al., 2009
yolk increased size, abnormal standard conditions Fig. 2 with image from Arrington et al., 2009

CITATIONS  (3)